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mountable competitive advantage over 10-23 and otherBreaking Up Is Easy To Do
possible ribonucleases when random DNA pools are(If You’re a DNA Enzyme used to initiate a selection experiment.
All of the new 8-17-like DNA enzymes share significantthat Cleaves RNA)
sequence and secondary structure elements. Further-
more, only four nucleotides are strictly conserved across
the set of enzymes; the remaining nine or so nucleotides
may have various identities. Based on these data, CruzIn this issue of Chemistry & Biology, Cruz et al. use in
et al. offer a modular structural proposal for the RNAvitro selection to select deoxyribozymes that collec-
cleavage activities (Figure 1). In this model, some DNAtively cleave almost any RNA dinucleotide junction [6].
nucleotides of a generic 8-17-like deoxyribozyme be-More remarkable is the finding that the new enzymes
long to the catalytic core, while others fine-tune theare related to the 8-17 deoxyribozyme that cleaves AG
structure for individual dinucleotide (NrN) specificitydinucleotide junctions.
without participating directly in catalysis. The nucleo-
bases of the substrate’s NrN junction are speculated to
About a decade ago, the first artificial DNA enzyme stack with a conserved nucleotide in the catalytic core.
(deoxyribozyme) was reported by Breaker and Joyce in This structural model is consistent with the experimen-
this journal [1]. The intervening years have seen signifi- tally favored cleavage of junctions that are flanked by
cant progress in developing DNA as a catalyst for many two purines, which stack better than pyrimidines. In
reactions [2]. The RNA backbone is a common cleavage addition, the model is consistent with the clear competi-
target for DNA enzymes, and the 10-23 and 8-17 deoxyri- tive advantage of 8-17-like sequences during selection.
bozymes [3] are now standard tools for in vitro RNA In particular, a compact catalytic core may imply that
cleavage [4] and for efforts at in vivo mRNA degradation only modest sequence changes elsewhere within the
[5]. Now, Cruz et al. have identified RNA-cleaving deoxy- DNA are sufficient to meet the varied structural demands
ribozymes that collectively cleave a wide range of RNA imposed by different nucleoside combinations that sur-
sequence junctions [6]. In an efficient parallel approach round the scissile phosphodiester bond.
using random DNA pools, they applied in vitro selection A general implication of the new report [6] is that it is
to pursue DNA enzymes that cut all sixteen possible NrN time for structural biologists to embrace DNA enzymes
junctions, where the single RNA linkage was embedded as they already have ribozymes [12]. DNA enzymes
within an otherwise all-DNA oligonucleotide substrate. clearly have much to reveal about how nucleic acids
For 14 out of the 16 possible NrN junctions, active Mn2- can catalyze chemical reactions. However, at present
dependent DNA enzymes were identified (one enzyme only one deoxyribozyme X-ray crystal structure has
for each junction). Surprisingly, sequencing reveals that been reported: that of 10-23, which crystallized in a
almost all of the new DNA enzymes are clearly related catalytically inactive 2:2 enzyme:substrate stoichiome-
to the 8-17 deoxyribozyme, which was previously re- try [13]. Close parallels are now firmly established be-
ported in several independent studies [3, 7–9].
The new experiments demonstrate that the 8-17 motif
is highly favored for RNA cleavage in DNA sequence
space. One intriguing facet of the new study is that
despite the repeated identification of 8-17-like se-
quences, the 10-23 deoxyribozyme motif was not ob-
served. This motif was originally reported at the same
time as 8-17 [3], and it is an excellent ribonuclease in its
own right [10]. Therefore, its absence is striking. Smaller
motifs have a competitive advantage during selection;
for example, the relatively small hammerhead ribozyme
is found preferentially over other possible ribozymes
in experiments starting with random RNA pools [11].
Figure 1. Cleavage of Nearly All Possible RNA Dinucleotide Junc-However, the 8-17 and 10-23 deoxyribozymes are about
tions by a Collection of New 8-17-like DNA Enzymes
equal in size: 13 and 15 nt in the “enzyme region,” re-
Based on the sequences of many new RNA-cleaving deoxyribo-spectively. So, why was the 10-23 not found at all? While
zymes that resemble the 8-17 DNA enzyme [3], Cruz et al. [6] offer
one always worries about selection artifacts such as a simple structural proposal to explain their wide substrate applica-
contamination, it is likely that 10-23 simply has more bility. In their model, the conserved catalytic core nucleotides (green)
interact with the substrate at the cleavable NrN ribonucleotide junc-sequence requirements than does 8-17 and thus is rep-
tion (purple). The remaining nucleotides of the DNA enzyme (black)resented at a lower frequency in random DNA pools.
facilitate the reaction by fine tuning the structure; thus, most dinucle-Indeed, the 10-23 is nearly intolerant to nucleotide sub-
otide junction sequences are cleavable because they depend onstitution in its enzyme region [10], whereas only four
the same catalytic residues. The illustrated role of base stacking
nucleotides are invariant in the collection of 8-17-like (•••) is speculative but consistent with the data. The mechanistic
enzymes described in the new report [6]. This difference role of the required divalent metal ion (M2) and the details of the
enzyme-substrate interactions are not yet known.in mutability is apparently sufficient to give 8-17 an insur-
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(Figure 1) [1]. The aureolic acids are neoplastic antibiot-Aureolic Acids: Similar Antibiotics
ics that act against gram-positive bacteria and also stopwith Different Biosynthetic the proliferation of tumor cells [2]. In the presence of
Gene Clusters Mg2, these compounds inhibit replication and tran-
scription processes by interacting with G-C-rich regions
in the minor groove of DNA [3]. Mithramycin (plicamycin),
the only clinically used aureolic acid, is currently in lim-
In this issue of Chemistry & Biology, Me´ndez and col- ited use for the treatment of some testicular cancers
leagues describe the sequence and organization of [4], Paget’s Bone Disease [5], and the treatment of hy-
the chromomycin gene cluster [20]. Unexpectedly, the percalciuria that results from certain tumors [6].
arrangement is starkly different from the mithramycin The biosynthetic pathway of mithramycin, a represen-
biosynthetic cluster, despite similarity in the individual tative member of the aureolic acids, was ultimately eluci-
genes and the near identical structures of the two dated by genetic studies of the producing organism,
antibiotic aureolic acids. Streptomyces argillaceus [1]. Sequencing of the mithra-
mycin biosynthetic gene cluster indicated that ten ace-
tate units are converted into a 20 carbon chain by theThe aureolic acids, chromomycin A3, mithramycin, oli-
combined action of an acyl carrier protein, a ketosyn-vomycin, UCH9, and durhamycin A, are a family of aro-
matic polyketides that share an identical tricyclic core thase, and a chain length factor in a mechanism that is
